Tari Leslie 4
4 · Cidara Therapeutics, Inc. · Filed Sep 13, 2023
Insider Transaction Report
Form 4
Tari Leslie
CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
2023-09-11$0.95/sh−18,469$17,509→ 275,710 total
Holdings
- 1,484(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.9472 to $0.9692, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.